Annals of Otology Rhinology & Laryngology · 1983 · 90 citations · 15 references
MedicineClinical SciencesOtolaryngologyImmunopathologyImmunotherapyLaryngologyInterferon-based TherapyLaryngeal CancerLaryngeal PapillomatosisRespiratory DiseaseDrug Toxicity TestingEvaluation Of Laryngeal LesionsLaryngeal PapillomaLaryngeal PathologyTreatment Periods
Preliminary findings are presented from an ongoing clinical trial of 19 patients with moderate-to-severe respiratory papillomatosis. The patients were treated with partially purified human leukocyte (alpha) interferon; after treatment periods ranging from 6 weeks to 12 months, six had no residual disease, seven had minimal residual disease, four had moderate disease not requiring rescue laryngoscopies, and two had not responded to treatment. No patient had to be removed from the study because of drug toxicity. Although these appear to be among the best results in the literature to date, we do not know how long treatment will be required.
15
Recurrent Respiratory Papillomatosis
M. Stuart Strong, Charles W. Vaughan, Gerald B. Healy et al. · Annals of Otology Rhinology & Laryngology · 1976 · 208 citations
Medicine, Oncology, Otolaryngology +12
Workshop on Papillomaviruses and Cancer
Joseph R. Coggin, Harald zur Hausen · Cancer Research · 1979 · 201 citations
Interferon Therapy in Juvenile Laryngeal Papillomatosis
S. Haglund, P.‐G. Lundquist, Kari Cantell et al. · Archives of Otolaryngology - Head and Neck Surgery · 1981 · 187 citations
Medicine, Oncology, Otolaryngology +13
Relationship between Condylomata and Laryngeal Papillomata
Cedric A. Quick, Richard A. Krzyzek, Susan Watts et al. · Annals of Otology Rhinology & Laryngology · 1980 · 187 citations